NineSigma, representing Merck, invites proposals for traditional herbal medicinal products that are able to treat specific health indications.


Product acquisition, licensing, proof of concept leading to scale-up to manufacturing, joint development, supplier agreement, contract research,

The success proposals will:

  • Have proven traditional use:
    • 30 years in the European Union (EU) or
    • 15 years in the EU and 30 years outside the EU;
  • Have safety data;
  • Have few or no side effects, be non-irritating and non-addictive;
  • Have data on plausibility of efficacy, ideally with clinical proof on humans;
  • Be able to be incorporated in a user-friendly and modern dosage form;
  • Be cost effective;
  • Preferably be commercially available or at least able to be commercialised within 1-3 years.

Deadline for extended submission is 31st March 2011.

For complete details on the RfP, visit or email: [email protected].

For Chinese version of the call and for other details please see the documents provided below:

Call details: Chinese version

Project description: Chinese version

Response template for non-confidential proposals: Chinese version

Print Friendly, PDF & Email